PTH1R and hypoparathyroidism: These results support the concept that the M‐PTH/PTHrP class of ligands could have beneficial pharmacological effects over alfacalcidol in the treatment of hypoparathyroidism, as suggested by a similar comparative study about the effects of a PTHR1 small molecule agonist and alfacalcidol on sCa and uCa has been reported previously.17